MIME-Version: 1.0
Date: Fri, 8 Oct 2021 09:43:33 +0000
References: <CACNgykMd06_8T=LBrb+Q19Fh2Q80fTJ7QQceabjTkE3ZPnMM8Q@mail.gmail.com>
	<CAH5Nud7C_G_BYO0Z7w-a13-35Suskb_3VfxcqTAUnkhLMV=-qA@mail.gmail.com>
In-Reply-To: <CAH5Nud7C_G_BYO0Z7w-a13-35Suskb_3VfxcqTAUnkhLMV=-qA@mail.gmail.com>
Message-ID: <CACNgykMdtB0SxLrRSnz6F6imR10G_xKQtobsdA2POA-7cFv1WQ@mail.gmail.com>
Subject: Re: On Bala's recommentation
From: Josh Klein <josh@josh.is>
To: Sigurbjorg Jonsdottir <silla@retinarisk.com>
Cc: =?UTF-8?B?w4ZnaXIgw57Ds3IgU3RlaW5hcnNzb24=?= <aegirthorst@retinarisk.com>
Content-Type: multipart/alternative; boundary="0000000000006f244305cdd436b4"

--0000000000006f244305cdd436b4
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

Thanks! I've passed this on to my contact at Sutter Health and he'll
connect directly if there's a fit. Keep me posted on feedback from your
medical team, and thanks!

All best,
Josh

=E1=90=A7

On Thu, Oct 7, 2021 at 6:23 PM Sigurbjorg Jonsdottir <silla@retinarisk.com>
wrote:

> Hi Josh,
>
> It was great meeting you this week to exchange views on our respective
> projects.
>
> As discussed, we'll share your deck with our medical team to seek their
> views, ideas and suggestions. We'll also further study your proposal and
> come back to you next week.
>
> Further also to our discussion I've attached our investor deck and the on=
e
> aimed at healthcare professionals.
>
> Please feel free to share with those you think might be interested and/or
> share with us contact details.
>
> We look forward to speaking with you soon again.
>
> All the best,
>
> Silla
>
>
>
>
>
> Sigurbj=C3=B6rg =C3=81sta J=C3=B3nsd=C3=B3ttir
> Chief Executive Officer
> _______________________________________
> RetinaRisk | Reykjavik | Iceland
> Email: *silla@retinarisk.com <silla@retinarisk.com>* | Mobile: +354
> 8947073
> w <http://www.retinarisk.com/>ww.retinarisk.com
> <http://www.retinarisk.com/>
>
>
>
>
> On Tue, Sep 28, 2021 at 9:25 AM Josh Klein <josh@josh.is> wrote:
>
>> Bala mentioned you're developing analytics for other risk vectors, such
>> as heart disease. Do you have an updated deck I could review? I'm pitchi=
ng
>> a CGM-based study to J&J and Novo Nordisk and would love to know if ther=
e's
>> any overlap!
>>
>> All best,
>> Josh
>>
>> =E1=90=A7
>>
> =E1=90=A7
>

--0000000000006f244305cdd436b4
Content-Type: text/html; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

<div dir=3D"ltr">Thanks! I&#39;ve passed this on to my contact at Sutter He=
alth and he&#39;ll connect directly=C2=A0if there&#39;s a fit. Keep me post=
ed on feedback from your medical team, and thanks!<div><br></div><div>All b=
est,</div><div>Josh</div><div><br></div></div><div hspace=3D"streak-pt-mark=
" style=3D"max-height:1px"><img alt=3D"" style=3D"width:0px;max-height:0px;=
overflow:hidden" src=3D"https://mailfoogae.appspot.com/t?sender=3Daam9zaEBq=
b3NoLmlz&amp;type=3Dzerocontent&amp;guid=3Da273fb50-b8c9-4655-9da6-ad20fd81=
45f8"><font color=3D"#ffffff" size=3D"1">=E1=90=A7</font></div><br><div cla=
ss=3D"gmail_quote"><div dir=3D"ltr" class=3D"gmail_attr">On Thu, Oct 7, 202=
1 at 6:23 PM Sigurbjorg Jonsdottir &lt;<a href=3D"mailto:silla@retinarisk.c=
om">silla@retinarisk.com</a>&gt; wrote:<br></div><blockquote class=3D"gmail=
_quote" style=3D"margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204=
,204);padding-left:1ex"><div dir=3D"ltr">Hi Josh,<div><br></div><div>It was=
 great meeting you this week to exchange views on our respective projects.<=
/div><div><br></div><div>As discussed, we&#39;ll share your deck with our m=
edical team to seek their views, ideas and suggestions. We&#39;ll also furt=
her study your proposal and come back to you next week.=C2=A0</div><div><br=
></div><div>Further also to our discussion I&#39;ve attached our investor d=
eck and the one aimed at healthcare professionals.=C2=A0</div><div><br></di=
v><div>Please feel free to share with those you think might be interested a=
nd/or share with us contact details.</div><div><br></div><div>We look forwa=
rd to speaking with you soon again.</div><div><br></div><div>All the best,<=
/div><div><br></div><div>Silla<br clear=3D"all"><div><div dir=3D"ltr"><div =
dir=3D"ltr"><div><div dir=3D"ltr"><div><div dir=3D"ltr"><div><div dir=3D"lt=
r"><div dir=3D"ltr"><div dir=3D"ltr"><p class=3D"MsoNormal" style=3D"margin=
-bottom:0.0001pt;line-height:normal"><span style=3D"color:rgb(0,0,0)"><br><=
/span></p><p class=3D"MsoNormal" style=3D"margin-bottom:0.0001pt;line-heigh=
t:normal"><span style=3D"color:rgb(0,0,0)"><br></span></p><p class=3D"MsoNo=
rmal" style=3D"margin-bottom:0.0001pt;line-height:normal"><span style=3D"co=
lor:rgb(0,0,0)"><img src=3D"https://ci4.googleusercontent.com/proxy/NeXcmdT=
hSBNzMYvuYK6pIopIZqU1_kaiTzcAAv81gCMqPKsjy7XUKOzGM2G1nleaPrVWCtgAFJnpjXSuiI=
cN0bpcX2tQPGj9bQ_jx7whztH_M-xOhJn-TNS0Q-Jx-1dZFTBQkruIzSjsHVGHN40RNtdKz_WaT=
WJZMtdSzfcGbEOSdUYunDCeldF63RmNt_TYxAxkAnvuC2S9jXuOTw=3Ds0-d-e1-ft#https://=
docs.google.com/uc?export=3Ddownload&amp;id=3D1zogsIL2Y4Jk0FV6OjrrUOH029i06=
6Xi5&amp;revid=3D0BwNeva3MjscWOSsya1FqQ0YzamFEZkpJNDN0eW1LbGFKbmtzPQ" width=
=3D"200" height=3D"45"><br></span></p><p class=3D"MsoNormal" style=3D"margi=
n-bottom:0.0001pt;line-height:normal"><span style=3D"color:rgb(0,0,0)"><br>=
</span></p><p class=3D"MsoNormal" style=3D"margin-bottom:0.0001pt;line-heig=
ht:normal"><span style=3D"color:rgb(0,0,0)">Sigurbj=C3=B6rg =C3=81sta J=C3=
=B3nsd=C3=B3ttir=C2=A0</span><br></p><span style=3D"color:rgb(0,0,0)">Chief=
 Executive Officer</span><br style=3D"color:rgb(0,0,0)"><span style=3D"colo=
r:rgb(0,0,0)">______________________________</span><span style=3D"color:rgb=
(0,0,0)">_________</span><br style=3D"color:rgb(0,0,0)"><span style=3D"colo=
r:rgb(0,0,0)">RetinaRisk | Reykjavik | Iceland</span><br style=3D"color:rgb=
(0,0,0)"><font color=3D"#000000">Email:=C2=A0</font><u><font color=3D"#0000=
ff"><a href=3D"mailto:silla@retinarisk.com" target=3D"_blank">silla@retinar=
isk.com</a></font></u><span style=3D"color:rgb(0,0,0)">=C2=A0</span><span s=
tyle=3D"color:rgb(0,0,0)">|=C2=A0Mobile: +354 8947073=C2=A0</span></div><di=
v dir=3D"ltr"><font color=3D"#0000ff"><a href=3D"http://www.retinarisk.com/=
" target=3D"_blank">w</a><a href=3D"http://www.retinarisk.com/" target=3D"_=
blank">ww.retinarisk.com</a></font><p class=3D"MsoNormal" style=3D"margin-b=
ottom:0.0001pt;line-height:normal;background-image:initial;background-posit=
ion:initial;background-repeat:initial"><br></p></div></div></div></div></di=
v></div></div></div></div></div></div><br></div><br><div class=3D"gmail_quo=
te"><div dir=3D"ltr" class=3D"gmail_attr">On Tue, Sep 28, 2021 at 9:25 AM J=
osh Klein &lt;<a href=3D"mailto:josh@josh.is" target=3D"_blank">josh@josh.i=
s</a>&gt; wrote:<br></div><blockquote class=3D"gmail_quote" style=3D"margin=
:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex"=
><div dir=3D"ltr">Bala mentioned you&#39;re developing=C2=A0analytics for o=
ther risk vectors, such as heart disease. Do you have an updated deck I cou=
ld review? I&#39;m pitching a CGM-based study to J&amp;J and Novo Nordisk a=
nd would love=C2=A0to know if there&#39;s any overlap!<div><br></div><div>A=
ll best,</div><div>Josh</div><div><br></div></div><div hspace=3D"streak-pt-=
mark" style=3D"max-height:1px"><img alt=3D"" style=3D"width: 0px; max-heigh=
t: 0px; overflow: hidden;" src=3D"https://ci5.googleusercontent.com/proxy/u=
6i6ebxipLLwmn6sPwLLMtlSw2s4c65PUMN9EjXlVfaP62QGqts8fZActLGcINGZV7nyYEjQYOHF=
U-XYPkf7HKuudZnV74sbjPmBVi0Vr-q54IKqhLOVJiaWOHczoxPyNAUDsifNv9bykBwB757nuQg=
_Oq0cGYWBgL4f-0m0jrXg9HXgPE89=3Ds0-d-e1-ft#https://mailfoogae.appspot.com/t=
?sender=3Daam9zaEBqb3NoLmlz&amp;type=3Dzerocontent&amp;guid=3Db3ee7338-b552=
-40aa-964e-cae1e304e614"><font color=3D"#ffffff" size=3D"1">=E1=90=A7</font=
></div>
</blockquote></div></div><div hspace=3D"streak-pt-mark" style=3D"max-height=
:1px"><img alt=3D"" style=3D"width: 0px; max-height: 0px; overflow: hidden;=
" src=3D"https://ci6.googleusercontent.com/proxy/J8JtMtFaWc89exTDPANchmOGZk=
teaMlMK_lIVndwYZKFRhlvqQWOwow-dLyiq1Tus9bohsRLjS7jkeATr_xPtcZk8BeJHZKjIBGBC=
9wor2xNbiPbIJH7wQ7D4jGIiWuGEDMIzCxlEczFSy9SPn--35vpkD6YvWb9UjOqE_iBlUdcGdE5=
TrEoFQuUgeOWBGW9dVXiO8y_=3Ds0-d-e1-ft#https://mailfoogae.appspot.com/t?send=
er=3Dac2lsbGFAcmV0aW5hcmlzay5jb20%3D&amp;type=3Dzerocontent&amp;guid=3D73ba=
0e34-2e33-47a4-a213-d7840c6af37d"><font color=3D"#ffffff" size=3D"1">=E1=90=
=A7</font></div>
</blockquote></div>

--0000000000006f244305cdd436b4--